Literature DB >> 7622571

The chemotactic response to PDGF-BB: evidence of a role for Ras.

V Kundra1, B Anand-Apte, L A Feig, B R Zetter.   

Abstract

The PDGF receptor-beta mediates both mitogenic and chemotactic responses to PDGF-BB. Although the role of Ras in tyrosine kinase-mediated mitogenesis has been characterized extensively, its role in PDGF-stimulated chemotaxis has not been defined. Using cells expressing a dominant-negative ras, we find that Ras inhibition suppresses migration toward PDGF-BB. Overexpression of either Ras-GTPase activating protein (Ras-GAP) or a Ras guanine releasing factor (GRF) also inhibited PDGF-stimulated chemotaxis. In addition, cells producing excess constitutively active Ras failed to migrate toward PDGF-BB, consistent with the observation that either excess ligand or excess signaling intermediate can suppress the chemotactic response. These results suggest that Ras can function in normal cells to support chemotaxis toward PDGF-BB and that either too little or too much Ras activity can abrogate the chemotactic response. In contrast to Ras overexpression, cells producing excess constitutively active Raf, a downstream effector of Ras, did migrate toward PDGF-BB. Cells expressing dominant-negative Ras were able to migrate toward soluble fibronectin demonstrating that these cells retained the ability to migrate. These results suggest that Ras is an intermediate in PDGF-stimulated chemotaxis but may not be required for fibronectin-stimulated cell motility.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622571      PMCID: PMC2120528          DOI: 10.1083/jcb.130.3.725

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  67 in total

1.  A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants.

Authors:  M Trahey; F McCormick
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

2.  Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.

Authors:  C W Benjamin; W G Tarpley; R R Gorman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 3.  Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium.

Authors:  P N Devreotes; S H Zigmond
Journal:  Annu Rev Cell Biol       Date:  1988

4.  A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain.

Authors:  A Hammacher; U Hellman; A Johnsson; A Ostman; K Gunnarsson; B Westermark; A Wasteson; C H Heldin
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

5.  Role of phosphatidylinositol kinase in PDGF receptor signal transduction.

Authors:  S R Coughlin; J A Escobedo; L T Williams
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

6.  Growth factor requirements of oncogene-transformed NIH 3T3 and BALB/c 3T3 cells cultured in defined media.

Authors:  X Zhan; M Goldfarb
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

7.  Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.

Authors:  L A Feig; G M Cooper
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.

Authors:  S J Leevers; H F Paterson; C J Marshall
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

9.  Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB.

Authors:  V Kundra; S Soker; B R Zetter
Journal:  Oncogene       Date:  1994-05       Impact factor: 9.867

10.  Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation.

Authors:  K E Bornfeldt; E W Raines; T Nakano; L M Graves; E G Krebs; R Ross
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  16 in total

1.  Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.

Authors:  H Okamoto; N Takuwa; T Yokomizo; N Sugimoto; S Sakurada; H Shigematsu; Y Takuwa
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 2.  Big roles for small GTPases in the control of directed cell movement.

Authors:  Pascale G Charest; Richard A Firtel
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

3.  Ras-GAP controls Rho-mediated cytoskeletal reorganization through its SH3 domain.

Authors:  V Leblanc; B Tocque; I Delumeau
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

4.  Effects of hepatocyte growth factor/scatter factor on the invasion of colorectal cancer cells in vitro.

Authors:  Hong-Wu Li; Ji-Xian Shan
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

5.  Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts.

Authors:  J Suzuki; Y Yamazaki; G Li; Y Kaziro; H Koide; L Guang
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

6.  Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

Authors:  Flavia V Castelino; Jon Seiders; Gretchen Bain; Sarah F Brooks; Christopher D King; James S Swaney; Daniel S Lorrain; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Arthritis Rheum       Date:  2011-05

7.  Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.

Authors:  S Silletti; S Paku; A Raz
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

8.  The distinct roles of Ras and Rac in PI 3-kinase-dependent protrusion during EGF-stimulated cell migration.

Authors:  Shu-Chin Yip; Mirvat El-Sibai; Salvatore J Coniglio; Ghassan Mouneimne; Robert J Eddy; Beth E Drees; Paul O Neilsen; Sumanta Goswami; Marc Symons; John S Condeelis; Jonathan M Backer
Journal:  J Cell Sci       Date:  2007-08-14       Impact factor: 5.285

9.  A portable chemotaxis platform for short and long term analysis.

Authors:  Chenjie Xu; Yuk Kee C Poh; Isaac Roes; Eoin D O'Cearbhaill; Mads Emil Matthiesen; Luye Mu; Seung Yun Yang; David Miranda-Nieves; Daniel Irimia; Jeffrey M Karp
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

10.  Microfluidic devices fitted with "flowver" paper pumps generate steady, tunable gradients for extended observation of chemotactic cell migration.

Authors:  Scott A Baldwin; Shawn M Van Bruggen; Joseph M Koelbl; Ravikanth Appalabhotla; James E Bear; Jason M Haugh
Journal:  Biomicrofluidics       Date:  2021-07-13       Impact factor: 3.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.